GoodRx Holdings, Inc. (GDRX) Reports In-Line Q1 EPS, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/9/2026
- Nasdaq ends sharply higher; chip surge offsets Iran worries
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Applied Materials surges as CEO signals multi-year chip boom
- Oil prices settle 2% lower as economic worries outweigh supply risks
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- GameStop stockholders approve share count increase to 2.5 billion
- Crude Inventory Rose 3 Million Barrels Last Week - EIA
- AI bubble fears mount as Zuckerberg admits agent delays and Burry shorts sector
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
GoodRx Holdings Inc. (GDRX) PT Lowered to $44 at Cowen
May 14, 2021 7:29 AM EDTCowen analyst Charles Rhyee lowered the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $44.00 (from $58.00) while maintaining an Outperform rating.
The analyst commented, "We believe shares could be weak following 2Q guide that suggests at first glance weaker than expected MAC growth... More
